AI-generated analysis. Always verify with the original filing.
Lipocine Inc. filed an 8-K on 2026-03-10 announcing financial results via Exhibit 99.1 press release under Item 2.02, which is not deemed 'filed' under Section 18 of the Exchange Act. The filing includes Item 9.01 listing Exhibit 99.1 as the press release.
Event Type
Disclosure
Mandatory
Variant
8-K
, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
Financial Statements and Exhibits. (d) Exhibits The following exhibits are filed with this report: Exhibit No. Description 99.1 Press Release announcing Financi